Topics

Summary of opinion: Nobivac Myxo-RHD Plus,myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant), 12/09/2019, Positive

11:30 EDT 13 Sep 2019 | European Medicines Agency

Summary of opinion: Nobivac Myxo-RHD Plus,myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant), 12/09/2019, Positive

Original Article: Summary of opinion: Nobivac Myxo-RHD Plus,myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant), 12/09/2019, Positive

NEXT ARTICLE

More From BioPortfolio on "Summary of opinion: Nobivac Myxo-RHD Plus,myxomatosis and rabbit haemorrhagic viral disease vaccine (live recombinant), 12/09/2019, Positive"

Quick Search

Relevant Topics

Vaccines
A vaccine is any preparation intended to produce immunity to a disease by stimulating the production of antibodies. It creates immunity but does not cause the disease. There are several differnt types of vaccine avalable; Killed microorganisms; which s...

Recombinant DNA
Recombinant DNA is the formation of a novel DNA sequence by the formation of two DNA strands. These are taken from two different organisms. These recombinant DNA molecules can be made with recombinant DNA technology. The procedure is to cut the DNA of ...